In the present study, starting from the characterization of a severe CID patient affected by ARPC1B deficiency presenting with an increased radiosensitivity (RS), we further investigated RS in other ARPC1B patients to assess whether it could be considered a trait of the disease. This evidence concerns the gene ARPC1B and combined immunodeficiency.